[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20054994L - Anvendelse av karbamazepinderivater for behandling av aggresjon hos demenspasienter - Google Patents

Anvendelse av karbamazepinderivater for behandling av aggresjon hos demenspasienter

Info

Publication number
NO20054994L
NO20054994L NO20054994A NO20054994A NO20054994L NO 20054994 L NO20054994 L NO 20054994L NO 20054994 A NO20054994 A NO 20054994A NO 20054994 A NO20054994 A NO 20054994A NO 20054994 L NO20054994 L NO 20054994L
Authority
NO
Norway
Prior art keywords
treatment
dementia patients
compound
aggression
formula
Prior art date
Application number
NO20054994A
Other languages
English (en)
Norwegian (no)
Inventor
Joshua Shua-Haim
Ferenc Martenyi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20054994L publication Critical patent/NO20054994L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20054994A 2003-04-01 2005-10-26 Anvendelse av karbamazepinderivater for behandling av aggresjon hos demenspasienter NO20054994L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45933803P 2003-04-01 2003-04-01
PCT/EP2004/003418 WO2004087166A1 (en) 2003-04-01 2004-03-31 Use of carbamazepine derivatives for the treatment of agitation in dementia patients

Publications (1)

Publication Number Publication Date
NO20054994L true NO20054994L (no) 2005-10-26

Family

ID=33131880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054994A NO20054994L (no) 2003-04-01 2005-10-26 Anvendelse av karbamazepinderivater for behandling av aggresjon hos demenspasienter

Country Status (25)

Country Link
US (2) US20070066593A1 (zh)
EP (1) EP1613328B8 (zh)
JP (1) JP2006522050A (zh)
KR (1) KR20050121236A (zh)
CN (1) CN1767833A (zh)
AT (1) ATE425756T1 (zh)
AU (1) AU2004226805B2 (zh)
BR (1) BRPI0408956A (zh)
CA (1) CA2521371A1 (zh)
DE (1) DE602004020060D1 (zh)
ES (1) ES2323270T3 (zh)
HK (1) HK1090543A1 (zh)
HR (1) HRP20050872A2 (zh)
IS (1) IS8096A (zh)
MA (1) MA27638A1 (zh)
MX (1) MXPA05010608A (zh)
NO (1) NO20054994L (zh)
NZ (1) NZ542554A (zh)
PL (1) PL1613328T3 (zh)
PT (1) PT1613328E (zh)
RU (1) RU2351338C2 (zh)
TN (1) TNSN05247A1 (zh)
TW (1) TW200501962A (zh)
WO (1) WO2004087166A1 (zh)
ZA (1) ZA200507439B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
GB0424563D0 (en) * 2004-11-05 2004-12-08 Novartis Ag Organic compounds
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP2312945A4 (en) * 2008-08-13 2012-05-09 Merck Sharp & Dohme PURE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER
CN102180965B (zh) * 2011-03-02 2014-01-01 广州金域医学检验中心有限公司 卡马西平免疫原、抗卡马西平特异性抗体、检测试剂及检测试剂盒
CN102183659B (zh) * 2011-03-02 2014-07-02 广州金域医学检验中心有限公司 一种卡马西平检测方法
RU2504367C1 (ru) * 2012-06-05 2014-01-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Амурская государственная медицинская академия" Минздравсоцразвития Российской Федерации Способ коррекции психического состояния пациентов и антиоксидантного статуса при органическом расстройстве личности

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
US3637661A (en) * 1970-03-04 1972-01-25 Ciba Geigy Corp 10-hydroxy-10 11-dihydro-dibenzazepine derivative
US5827819A (en) * 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
JP3057471B2 (ja) * 1993-06-07 2000-06-26 武田薬品工業株式会社 アンジオテンシンｉｉ介在性諸疾患の予防または治療剤
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
US5736647A (en) * 1995-08-07 1998-04-07 Oval Corporation Vortex flow meter detector and vortex flow meter
ID28441A (id) * 1998-10-16 2001-05-24 Janssen Pharmaceutica Nv Terapi untuk memperbaiki kesadaran
WO2001049307A1 (en) * 1999-12-30 2001-07-12 Proteotech, Inc. Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses
GB0113663D0 (en) * 2001-06-05 2001-07-25 Novartis Ag Use of organic compounds
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients

Also Published As

Publication number Publication date
TW200501962A (en) 2005-01-16
MXPA05010608A (es) 2005-11-23
AU2004226805A1 (en) 2004-10-14
PT1613328E (pt) 2009-06-15
HK1090543A1 (en) 2006-12-29
CA2521371A1 (en) 2004-10-14
DE602004020060D1 (de) 2009-04-30
JP2006522050A (ja) 2006-09-28
BRPI0408956A (pt) 2006-04-04
ATE425756T1 (de) 2009-04-15
ZA200507439B (en) 2007-06-27
EP1613328B8 (en) 2009-06-10
EP1613328A1 (en) 2006-01-11
NZ542554A (en) 2008-10-31
WO2004087166A1 (en) 2004-10-14
HRP20050872A2 (en) 2006-12-31
US20070066593A1 (en) 2007-03-22
US20090192142A1 (en) 2009-07-30
KR20050121236A (ko) 2005-12-26
TNSN05247A1 (en) 2007-06-11
PL1613328T3 (pl) 2009-08-31
ES2323270T3 (es) 2009-07-10
MA27638A1 (fr) 2005-11-01
AU2004226805B2 (en) 2008-03-06
CN1767833A (zh) 2006-05-03
RU2005133478A (ru) 2007-06-10
EP1613328B1 (en) 2009-03-18
IS8096A (is) 2005-10-27
RU2351338C2 (ru) 2009-04-10

Similar Documents

Publication Publication Date Title
HK1090543A1 (en) Use of carbamazepine derivatives for the treatment of agitation in dementia patients
MY138352A (en) Benzothiazole derivatives
TR200102782T2 (tr) Bisiklik heterosikleler, bu bileşikleri ihtiva eden farmasötik kompozisyonlar
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
BR0317600A (pt) ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
BR0317572A (pt) Benzoxazinas e seus derivados como inibidores de pi3ks
ATE365742T1 (de) 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
WO2007143523A8 (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
BRPI0617673C1 (pt) composições de inibidores de fosfodiesterase do tipo iv
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
NO20032261L (no) Medisinske preparater
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
MY133512A (en) Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors
WO2006038006A3 (en) 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders
CO5700775A2 (es) Nuevos derivados triciclicos como antagonistas de ltd4
TW200519101A (en) Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
EA200601687A1 (ru) Тетрагидроизохинолиновые и тетрагидробензазепиновые производные (варианты), фармацевтическая композиция и фармацевтический набор, лекарственное и эталонное средство для тест-систем на их основе, способ лечения и профилактики заболевания, при котором благоприятна понижающая регуляция или ингибирование экспрессии или функции рецептора igf-1
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
TW200519102A (en) Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
TW200607498A (en) Agents for prevention or treatment of diseases associated with endothelial hyperproliferation
NO20061966L (no) Bicyklo[3.1.1.]heptansubstituerte benzimidazolon- og kinazolinonderivater som agonister for humane ORL1 reseptorer
EA200900313A1 (ru) Производные бензо[1,2,3]тиадиазина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application